Track topics on Twitter Track topics that are important to you
Vancouver, British Columbia - November 8, 2019 (Newsfile Corp.) (Investorideas.com Newswire) Calyx Ventures Inc. (TSXV: CYX) ("Calyx" or the "Company") is pleased to announce that its wholly owned subsidiary LeafHub Technologies Inc. has entered into an agreement with Nibbler Technology Inc. ("Nibbler") to assist with applying and acquiring a "Sales for Medical Purposes" license under the Cannabis Act (Canada).NEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...